Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
about
Translational utility of experimental autoimmune encephalomyelitis: recent developmentsThe paracaspase MALT1: biological function and potential for therapeutic inhibitionMALT1 is not alone after all: identification of novel paracaspasesThe paracaspase MALT1 mediates CARD14-induced signaling in keratinocytesCleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation.Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemiaOverexpression of MALT1-A20-NF-κB in adult B-cell acute lymphoblastic leukemiaThe Paracaspase MALT1.MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.Synthesis and biological evaluation of novel propargylquinobenzothiazines and their derivatives as potential antiproliferative, anti-inflammatory, and anticancer agents.MALT1 is an intrinsic regulator of regulatory T cells.MALT1 promotes melanoma progression through JNK/c-Jun signalingMALT1 protease: equilibrating immunity versus tolerance.MALT1 controls attenuated rabies virus by inducing early inflammation and T cell activation in the brain.MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
P2860
Q26775820-B22BBD07-84C5-489D-8638-ADFB235B6570Q26778357-9729B73F-FD93-4C47-82E1-F3FA6FEAA5D6Q28267461-43DC201B-35B5-4AE0-BE3E-330D228A9B9FQ28975763-7A9F373A-E327-495E-9116-ADF872526D70Q34441762-1DE0C963-B462-4E15-8CA7-1297C91355B1Q34492636-F13A56E7-E70F-4FA1-A4F5-56FBB67FF5F3Q35888867-528F92C6-4048-46C4-BF66-FC2BF2F3CEF2Q36563807-771F402D-0656-4E27-BD8A-4E2D81719AA4Q37327533-99BCF66D-2A15-45C9-85D8-FDD7D05550F0Q38495157-AC72E4FC-4C1F-4FD5-A455-3B663CC2B9FEQ38758568-4A31DA63-1AF1-4B21-B588-D1F6980C6D0FQ40503533-236D04FA-A235-4952-B369-6DA458C7F259Q41228856-03D0C472-2E2F-4304-B7F1-6BBCE6D971B5Q43088894-A617E443-79E6-4C68-8C15-5726731C1346Q47549174-AEC6FB8A-E883-4004-9651-5F787C9C51DBQ48103382-02ED8AE4-9EFE-406A-BBCF-08C7F1190CAFQ54976736-0F3DDD37-1490-4DD2-988C-E9BD4CD49201
P2860
Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological inhibition of ...... e model of multiple sclerosis.
@ast
Pharmacological inhibition of ...... e model of multiple sclerosis.
@en
type
label
Pharmacological inhibition of ...... e model of multiple sclerosis.
@ast
Pharmacological inhibition of ...... e model of multiple sclerosis.
@en
prefLabel
Pharmacological inhibition of ...... e model of multiple sclerosis.
@ast
Pharmacological inhibition of ...... e model of multiple sclerosis.
@en
P2093
P2860
P50
P356
P1476
Pharmacological inhibition of ...... se model of multiple sclerosis
@en
P2093
Annelies Demeyer
Conor Mc Guire
Daniel Nagel
Geert van Loo
Lynn Elton
Marco Prinz
Peter Wieghofer
Sofie Voet
P2860
P2888
P356
10.1186/1742-2094-11-124
P577
2014-07-21T00:00:00Z
P5875
P6179
1034486883